Medicortex Finland Oy

Turkulaisen Medicortex Finland Oyj:n kehittämän uudenlaisiin biomerkkiaineisiin perustuvan pikatestin avulla voitaneen pian havaita aivovamma syljestä tai virtsasta. Yhtiön käsityksen mukaan maailmalta ei löydy samankaltaista nopeaa ja helppokäyttöistä patentoitua testiä. Yhtiö hakee nyt uusia sijoittajia kesäkuun listautumisannissaan.

10
Jun

10.6.2022

Medicortex Finland Oyj on julkaissut pörssitiedotteen suunnittelemastaan Listautumisannista

10
Jun

10.6.2022

Medicortex Finland Plc has published a press release regarding announcement of IPO

23
Mar

23.3.2022

Extraordinary General Meeting / Ylimääräinen yhtiökokous

22
Mar

22.3.2022

Annual General Meeting / Yhtiökokous

22
Mar

22.3.2022

Medal award ceremony for Dr. Mårten Kvist

8
Mar

8.3.2022

Muistutus osakkeiden siirtämisestä arvo-osuusjärjestelmään

4
Feb

4.2.2022

Medicortexin ilmoitus Virallisessa Lehdessä

24
Jan

24.1.2022

Medicortex featured in Good News From Finland

18
Jan

18.1.2022

New key persons joining Medicortex Finland

10
Jan

10.1.2022

CEO, Dr. Adrian Harel interviewed on a medicine radio talk show

7
Jan

7.1.2022

Extraordinary general meeting / Ylimääräinen yhtiökokous

17
Dec

17.12.2021

Happy holidays

13
Dec

13.12.2021

Turun Sanomat kirjoitti artikkelin Medicortexista

9
Dec

9.12.2021

How repeated concussions affect your brain

9
Dec

9.12.2021

Patent granted in Israel

12
Nov

12.11.2021

Results of the First Clinical Study are Published in Frontiers in Biomarkers of Brain Injury

28
Sep

28.9.2021

Medicortex Closes Successful Pre-IPO Funding Round

9
Aug

9.8.2021

Medicortex in a Swedish Newspaper

9
Aug

9.8.2021

Medicortex and Dividend Announce a Pre-IPO Investment / Medicortex ja Dividend Julkistavat Ennakko-IPO Sijoituksen

6
Aug

6.8.2021

Press Release / Lehdistötiedote

6
Aug

6.8.2021

Medicortex in Newspaper / Medicortex Turun Sanomissa

3
Aug

3.8.2021

Patent issued in Canada / Patentti myönnetty Kanadassa

27
Apr

27.4.2021

Annual General Meeting on 28th May 2021 / Varsinainen yhtiökokous 28.5.2021

15
Apr

15.4.2021

Medicortex on saanut kerättyä kaikki potilaat kolmanteen kliiniseen tutkimukseen

15
Apr

15.4.2021

Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland

8
Mar

8.3.2021

Business Finland Granted Funding for Medicortex

8
Mar

8.3.2021

Business Finland myönsi rahoitusta Medicortexille

12
Jan

12.1.2021

Share price now 6.40 euro / Osakkeen hinta nyt 6,40 euroa

13
Nov

13.11.2020

A utility patent was approved for Medicortex in China

28
Sep

28.9.2020

Happy New (Jewish) Year!

18
Sep

18.9.2020

Merkittävä saavutus – Medicortexille myönnettiin patentti Yhdysvalloissa

18
Sep

18.9.2020

Major achievement – A patent was issued in the United States

31
Aug

31.8.2020

Medicortex Finland Oy announces reaching the halfway point in the clinical trial for children and adolescents.

7
Aug

7.8.2020

Live Webinaari 7.8.2020

9
Jun

9.6.2020

Medicortex Announces Progression in the Clinical Trial for Detection of Mild Traumatic Brain Injury in Children

5
Jun

5.6.2020

Medicortex is looking for new investors

2
Jun

2.6.2020

Annual General Meeting held / Yhtiökokous pidetty

29
May

29.5.2020

Medicortexista artikkeli Turkun Sanomissa.

29
May

29.5.2020

Medicortex received a 50 k€ grant / Medicortex Finland Oy:lle myönnettiin 50k€ suuruinen kehittämisavustus

4
May

4.5.2020

Annual General Meeting on 29th May 2020 / Varsinainen yhtiökokous 29.5.2020

16
Apr

16.4.2020

Medicortex Finland Oy Announces Issuance of a Patent for Brain Injury Biomarker

16
Apr

16.4.2020

Medicortex CEO, Dr Adrian Harel participated in a pitching to Finnish business angels

8
Apr

8.4.2020

Detecting sport concussions with a disposable quick-test developed by Medicortex

1
Apr

1.4.2020

CEO, Dr Adrian Harel discusses diagnosing sport concussions in a sport medicine radio talk show with Dr Robert Weil

23
Mar

23.3.2020

Patent Issued in Israel / Patentti Israelissa

11
Mar

11.3.2020

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous

9
Mar

9.3.2020

A clinical trial for children started / Kliininen tutkimus lapsipotilaille alkanut

11
Feb

11.2.2020

Medicortex presented at LSX World Congress in London

26
Nov

26.11.2019

Medicortex wins the Life Science Pitching competition at Y Science 2019

5
Nov

5.11.2019

Medicortex featured in a news podcast

18
Oct

18.10.2019

Medicortex featured in an Israeli newspaper, News1

23
Sep

23.9.2019

Medicortex was chosen as the winner of TechBBQ’s pitching competition!

28
Aug

28.8.2019

Medicortex was accepted into the Nordic Health Tech Talents program

30
Jul

30.7.2019

En hjärnskakning, hur allvarlig är en sådan egentligen? / A concussion, how serious is one really?

30
Jul

30.7.2019

Medicortex featured in The Jerusalem Post

16
Jul

16.7.2019

Medicortex in Science and Enterprise

3
Jul

3.7.2019

Medicortex Turun Sanomissa: "Turkulaisyritykselle yli miljoonan dollarin tutkimusrahoitus Yhdysvaltain puolustusministeriöltä"

3
Jul

3.7.2019

Medicortex Announces Receiving a 1.1 Million Dollars Research Grant from the US Department of Defense / Medicortex Finland Oy:lle tutkimusrahoitusta Yhdysvaltain Puolustusministeriöltä

1
Jul

1.7.2019

Medicortex hakee tuotekehityspäällikköä

11
Jun

11.6.2019

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous

5
Jun

5.6.2019

Annual General Meeting held / Yhtiökokous pidetty

10
May

10.5.2019

Annual General Meeting on 29th May / Varsinainen yhtiökokous 29.5.

18
Apr

18.4.2019

Happy Easter and happy Passover

28
Mar

28.3.2019

Medicortex presenting in an investors seminar / Medicortex esiintyi Turussa sijoittajatapahtumassa

13
Mar

13.3.2019

Medicortex featuring in Turun Sanomat newspaper / Medicortex Turun Sanomissa

5
Mar

5.3.2019

Clinical Trial Completed / Kliininen tutkimus päättynyt

14
Feb

14.2.2019

Investors’ event in Tampere / Sijoittaja-tapahtuma Tampereella

28
Jan

28.1.2019

Medicortex - SME of the Month in January. Read the interview by Europabio.

8
Jan

8.1.2019

A slide deck video

28
Dec

28.12.2018

Medicortex featuring in a premium magazine

7
Dec

7.12.2018

Medicortex was shortlisted as a finalist to the Europabio´s Most Innovative European Biotech SME Awards

29
Nov

29.11.2018

Scientific and Clinical Advisory Board had a meeting

1
Nov

1.11.2018

Medicortex is featured in Good News from Finland / Medicortex näkyvästi esillä Good News from Finland -sivustolla

30
Oct

30.10.2018

Medicortex was accepted to the European Union Horizon 2020 funding program

7
Sep

7.9.2018

Medicortex presentation in Monaco

4
Sep

4.9.2018

Third study site has been added to the clinical trial

3
Sep

3.9.2018

Happy New (Jewish) Year!

29
Aug

29.8.2018

Medicortex Finland Oy: Clinical Trial Extended for Detection of Mild Traumatic Brain Injury

20
Aug

20.8.2018

Medicortex presentation in Monaco

12
Jun

12.6.2018

Article in Turun Sanomat about Medicortex Finland Oy / Turun Sanomissa artikkeli Medicortexista

31
May

31.5.2018

Approval of a patent for a drug candidate / Lääkemolekyylipatentti hyväksytty

22
May

22.5.2018

Medicortex Finland Announces Agreement with Pro-Lab / Yhteistyösopimus Pro-Lab:n kanssa

8
May

8.5.2018

Annual General Meeting on 30th May / Varsinainen yhtiökokous 30.5.

2
May

2.5.2018

Mayor of Turku visiting Medicortex / Turun kaupunginjohtaja vierailulla

21
Mar

21.3.2018

Haastattelu Aivovammaliiton lehdessä / Interview in the magazine of Brain Injury Association

13
Feb

13.2.2018

The second brain injury awareness meeting 12.2.2018

1
Feb

1.2.2018

Scientific advisory board gather together first time in a new composition

11
Jan

11.1.2018

We are opening new funding round with old terms

28
Dec

28.12.2017

New Clinical Trial Started / Kliininen tutkimus alkanut

5
Dec

5.12.2017

Onnea satavuotias Suomi!

14
Nov

14.11.2017

Pikatesti urheiluvammojen diagnostiikan tueksi (In English: Rapid TBI test to help diagnose sport injuries)

8
Nov

8.11.2017

Medicortex participated in a press conference #pääasia

18
Oct

18.10.2017

Extraordinary General Meeting / Ylimääräinen yhtiökokous

3
Oct

3.10.2017

A New Clinical Trial for a Novel Brain Injury Biomarker

19
Sep

19.9.2017

Scientific Advisory Board (SAB) had a meeting

5
Sep

5.9.2017

Happy New (Jewish) Year!

2
Aug

2.8.2017

An interview published

12
Jun

12.6.2017

Crowdfunding successfully completed / Joukkorahoituskampnaja päättynyt

30
May

30.5.2017

Tom Palenius joins Medicortex's Board of Directors

18
May

18.5.2017

Development of the brain injury test sped up by crowdfunding

2
May

2.5.2017

Medicortex's Annual General Meeting on May 29th

2
May

2.5.2017

Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland

20
Apr

20.4.2017

Military accidents can be diagnosed using Medicortex's kit - A new press release

11
Apr

11.4.2017

Medicortex Finland using crowdfunding to help develop brain injury diagnostics

7
Apr

7.4.2017

Newsletter 2/2017: Three questions about the Medicortex's idea

Medicortex's crowdfunding at Invesdor is going on and we have received a lot of questions regarding the idea. We would like to answer three main questions here.

31
Mar

31.3.2017

22.10.2015

20.4.2015

"The silent epidemic" on radio podcast 22nd April at 10 pm EST

Dr. Adrian Harel will be talking about Traumatic Brain Injury in Kim Justus' Brain Injury Radio on the 22nd April at 10pm. EST.

16
Mar

16.3.2015